1185 related articles for article (PubMed ID: 27959396)
1. Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells.
Luo Y; Che W; Zhao M
Int J Mol Med; 2017 Feb; 39(2):297-306. PubMed ID: 27959396
[TBL] [Abstract][Full Text] [Related]
2. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
[TBL] [Abstract][Full Text] [Related]
3. Levobupivacaine attenuates lipopolysaccharide-induced acute lung injury.
Guo D; Li K; Yang M; Zhang H; Miao Y
Fundam Clin Pharmacol; 2016 Aug; 30(4):307-15. PubMed ID: 26991027
[TBL] [Abstract][Full Text] [Related]
4. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
Feng G; Sun B; Li TZ
Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
[TBL] [Abstract][Full Text] [Related]
5. Propofol Protects Rats and Human Alveolar Epithelial Cells Against Lipopolysaccharide-Induced Acute Lung Injury via Inhibiting HMGB1 Expression.
Wang X; Liu C; Wang G
Inflammation; 2016 Jun; 39(3):1004-16. PubMed ID: 26956470
[TBL] [Abstract][Full Text] [Related]
6. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
Liu J; Huang X; Hu S; He H; Meng Z
Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
[TBL] [Abstract][Full Text] [Related]
8. Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury.
Qiushi W; Guanghua L; Guangquan X
Eur J Pharmacol; 2015 Mar; 750():32-8. PubMed ID: 25620130
[TBL] [Abstract][Full Text] [Related]
9. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of versican V1 induces a severe inflammatory response in LPS-induced acute lung injury via the TLR2-NF-κB signaling pathway in C57BL/6J mice.
Xu L; Xue T; Zhang J; Qu J
Mol Med Rep; 2016 Jun; 13(6):5005-12. PubMed ID: 27109786
[TBL] [Abstract][Full Text] [Related]
11. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
12. Hesperidin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting HMGB1 release.
Liu XX; Yu DD; Chen MJ; Sun T; Li G; Huang WJ; Nie H; Wang C; Zhang YX; Gong Q; Ren BX
Int Immunopharmacol; 2015 Apr; 25(2):370-6. PubMed ID: 25724384
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats.
Li G; Li J; Zhou Q; Song X; Liang H; Huang L
Tohoku J Exp Med; 2010 Sep; 222(1):7-13. PubMed ID: 20805679
[TBL] [Abstract][Full Text] [Related]
14. Sodium butyrate alleviates LPS-induced acute lung injury in mice via inhibiting HMGB1 release.
Li N; Liu XX; Hong M; Huang XZ; Chen H; Xu JH; Wang C; Zhang YX; Zhong JX; Nie H; Gong Q
Int Immunopharmacol; 2018 Mar; 56():242-248. PubMed ID: 29414658
[TBL] [Abstract][Full Text] [Related]
15. Paeonol attenuates acute lung injury by inhibiting HMGB1 in lipopolysaccharide-induced shock rats.
Liu X; Xu Q; Mei L; Lei H; Wen Q; Miao J; Huang H; Chen D; Du S; Zhang S; Zhou J; Deng R; Li Y; Li C; Li H
Int Immunopharmacol; 2018 Aug; 61():169-177. PubMed ID: 29883962
[TBL] [Abstract][Full Text] [Related]
16. Timosaponin B-II inhibits lipopolysaccharide-induced acute lung toxicity via TLR/NF-κB pathway.
Zhang T; Wang J; Wang S; Ma C
Toxicol Mech Methods; 2015; 25(9):665-71. PubMed ID: 26540118
[TBL] [Abstract][Full Text] [Related]
17. Fisetin Alleviates Lipopolysaccharide-Induced Acute Lung Injury via TLR4-Mediated NF-κB Signaling Pathway in Rats.
Feng G; Jiang ZY; Sun B; Fu J; Li TZ
Inflammation; 2016 Feb; 39(1):148-157. PubMed ID: 26272311
[TBL] [Abstract][Full Text] [Related]
18. Insulin reduces LPS-induced lethality and lung injury in rats.
Liu ML; Dong HY; Zhang B; Zheng WS; Zhao PT; Liu Y; Niu W; Xu DQ; Li ZC
Pulm Pharmacol Ther; 2012 Dec; 25(6):472-7. PubMed ID: 22982561
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G
Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhizin inactivates toll-like receptor (TLR) signaling pathway to reduce lipopolysaccharide-induced acute lung injury by inhibiting TLR2.
Kong D; Wang Z; Tian J; Liu T; Zhou H
J Cell Physiol; 2019 Apr; 234(4):4597-4607. PubMed ID: 30203548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
